How to buy Recce Pharmaceuticals shares | A$1.1

Recce Pharmaceuticals Ltd is a biotechnology business based in Australia. Recce Pharmaceuticals shares (RCE) are listed on the Australian Securities Exchange (ASX) and all prices are listed in Australian Dollars. Its last market close was $1.1 – an increase of 2.8% over the previous week. Recce Pharmaceuticals has a trailing 12-month revenue of around $1.1 million.

How to buy shares in Recce Pharmaceuticals

1. Compare share trading platforms. To buy shares listed in Australia, you'll need to sign up to a broker with access to the Australian Securities Exchange (ASX). Our table below can help you choose.
2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and tax file number. Fund your account with a bank transfer, PayPal or debit card.
3. Search for Recce Pharmaceuticals . Find the share by name or ticker symbol: RCE. Research its history to confirm it's a solid investment against your financial goals.
4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Recce Pharmaceuticals reaches your desired price. To spread out your risk, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
5. Decide on how many to buy. At today's price of $1.1, weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs.
6. Check in on your investment. Congratulations, you own a part of Recce Pharmaceuticals . Optimise your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

🧪How we chose these brokers

For our Top Picks, we compared our Finder partners using a proprietary algorithm in August 2020. Keep in mind that our top picks may not always be the best for you, and you're encouraged to compare for yourself to find one that works for you. Read our full methodology here to find out more.

How has coronavirus impacted Recce Pharmaceuticals 's share price?

Since the stock market crash in March caused by coronavirus, Recce Pharmaceuticals 's share price has had significant positive movement.

Its last market close was $1.1, which is 55.00% up on its pre-crash value of $0.495 and 423.81% up on the lowest point reached during the March crash when the shares fell as low as $0.21.

If you had bought $1,000 worth of Recce Pharmaceuticals shares at the start of February 2020, those shares would have been worth $808.82 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth $3,235.30.

Recce Pharmaceuticals share price

Use our graph to track the performance of RCE stocks over time.

Recce Pharmaceuticals shares at a glance

• Key figures

Information last updated 2020-10-21.

Latest market close	AUDA$1.1
52-week range	AUDA$0.21 - AUDA$1.875
50-day moving average	AUDA$1.3582
200-day moving average	AUDA$0.9656
Target price	N/A
PE ratio	N/A
Dividend yield	N/A (0%)
Earnings per share (TTM)	AUDA$-0.03

Share Trading Account Offer

IG Share Trading Offer

AUD 8

Standard brokerage - Australian shares

Share Trading Account Offer

Competitive broker fees on Australian and international shares

• Brokerage - AU shares: From AUD 5 or 0.05%
• Brokerage - US shares: USD 0
• Sign-up process: Instant
• Support - After hours: Yes

Go to site

More info

Important: Share trading carries risk of capital loss.

Compare share trading platforms

The value of your investments can fall as well as rise and you may get back less than you invested. Past performance is no indication of future results.

Is it a good time to buy Recce Pharmaceuticals stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Technical Analysis of Recce Pharmaceuticals Ltd by TradingView

Recce Pharmaceuticals price performance over time

Historical closes compared with the close of A$1.1 on 2020-10-22

1 week (2020-10-16)	2.80%
1 month (2020-09-25)	-17.91%
3 months (2020-07-24)	-16.35%
6 months (2020-04-24)	205.56%

1 year (2019-10-24)	323.08%
2 years (2018-10-24)	528.57%
3 years (2017-10-24)	511.11%
5 years (2015-10-22)	N/A

Recce Pharmaceuticals financials

Revenue TTM	$1.1 million
Gross profit TTM	$-977,344
Return on assets TTM	-128.6%
Return on equity TTM	-452.73%
Profit margin	0%
Book value	0.017
Market capitalisation	$191 million

TTM: trailing 12 months

Recce Pharmaceuticals share dividends

We're not expecting Recce Pharmaceuticals to pay a dividend over the next 12 months.

Recce Pharmaceuticals share price volatility

Over the last 12 months, Recce Pharmaceuticals 's shares have ranged in value from as little as $0.21 up to $1.875. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (AU average) beta is 1, while Recce Pharmaceuticals 's is 1.6601. This would suggest that Recce Pharmaceuticals 's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Recce Pharmaceuticals overview

Recce Pharmaceuticals Ltd, a biotechnology company, engages in the research, development, and commercialization of synthetic antibiotics in Australia, the United States, and the United Kingdom. The company's lead candidate is RECCE 327 to treat blood infections and sepsis derived from E. coli and S. aureus bacteria, including their superbug forms. It also develops RECCE 529, a synthetic anti-infective for viral infections; and RECCE 435, a synthetic polymer antibiotics. The company was formerly known as Recce Limited and changed its name to Recce Pharmaceuticals Ltd in November 2017. Recce Pharmaceuticals Ltd was incorporated in 2007 and is headquartered in Sydney, Australia.

Frequently asked questions

• What percentage of Recce Pharmaceuticals is owned by insiders?

  Currently 42.305% of Recce Pharmaceuticals shares are held by insiders.

• When does the fiscal year end for Recce Pharmaceuticals ?

  Recce Pharmaceuticals 's fiscal year ends in June.

• Where is Recce Pharmaceuticals based?

  Recce Pharmaceuticals 's address is: Gateway Tower, Sydney, NSW, Australia, 2000

• What is Recce Pharmaceuticals 's ISIN number?

  Recce Pharmaceuticals 's international securities identification number is: AU000000RCE5